AZIYO BIOLOGICS
Aziyo is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. From our proprietary tissue processing platforms, we have developed a portfolio of advanced regenerative medical products that are designed to be very similar to natural biological material.
AZIYO BIOLOGICS
Industry:
Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Silver Spring, Maryland, United States
Country:
United States
Website Url:
http://www.aziyo.com
Total Employee:
101+
Status:
Active
Contact:
(855)416-0596
Email Addresses:
[email protected]
Total Funding:
44.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Deerfield
Deerfield investment in Venture Round - Aziyo Biologics
HighCape Partners
HighCape Partners investment in Venture Round - Aziyo Biologics
MidCap Financial
MidCap Financial investment in Venture Round - Aziyo Biologics
Key Employee Changes
Official Site Inspections
http://www.aziyo.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.65 K
- Host name: 93.172.196.104.bc.googleusercontent.com
- IP address: 104.196.172.93
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Aziyo Biologics"
Elutia - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (855)416-0596 Elutia is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients …See details»
Elutia – Humanizing Medicine
Elutia offers a proprietary drug-eluting biologic technology: a fusion of natural biologic material and extended antibiotic release, perfected for device implantation and soft tissue …See details»
Aziyo Company Profile - Office Locations, Competitors, Revenue
Nov 6, 2023 Aziyo has 3 employees across 3 locations and $24.75 m in annual revenue in FY 2023. See insights on Aziyo including office locations, competitors, revenue, financials, …See details»
Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on …
Sep 6, 2023 – Company to begin trading under new ticker symbol “ELUT” – SILVER SPRING, Md., September 6, 2023 — Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”) today announced a …See details»
Aziyo Biologics, Inc. | LinkedIn
Aziyo Biologics is a fully integrated, commercially oriented regenerative medicine company. Since its founding in 2015 the Company has expanded through acquisitions and strategic …See details»
Reimagined Regenerati - investors.aziyo.com
4 Recent Updates Appointed Co-founder Randy Mills, Ph.D. as Interim President & CEO •Co-founded Aziyo in 2015 with Kevin Rakin (Aziyo Executive Chairman) •Previous President/CEO …See details»
Aziyo Biologics - Overview, News & Similar companies - ZoomInfo
Mar 16, 2023 Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023 SILVER SPRING, Md., May 03, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, …See details»
Aziyo Biologics Reports Highest Sales and Gross Profit in Company ...
Mar 31, 2023 - All Four Business Segments Achieved Growth Led by Strong SimpliDerm and CanGaroo Sales - SILVER SPRING, Md., May 10, 2023 (GLOBE NEWSWIRE) -- Aziyo …See details»
Ronald Lloyd Announced as New President and CEO of Aziyo …
– June 4, 2018 – Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today the appointment of Ronald (Ron) Lloyd as President and Chief Executive …See details»
Aziyo Biologics Co-Founder and Regenerative Medicine
Aug 9, 2022 Randy Mills, Ph.D., co-founder of Aziyo Biologics, is an internationally recognized expert in regenerative medicine who has led pioneering biotechnology organizations that have …See details»
Aziyo Continues Building New Breed of Regenerative Medicine …
– Aziyo Biologics, Inc. a fully integrated regenerative medicine company, today announced it has completed an asset purchase agreement with CorMatrix® Cardiovascular, Inc. for the …See details»
Aziyo Biologics Provides Business Update and Preliminary Third …
Oct 25, 2021 Aziyo announced preliminary revenue of approximately $11.5 million for the three months ended September 30, 2021, compared to $11.8 million for the three months ended …See details»
Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public ...
Aziyo Biologics. SILVER SPRING, Md., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products …See details»
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution …
SILVER SPRING, Md., April 20, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve …See details»
Aziyo Biologics Reports Second Quarter 2023 Financial Results ...
Aug 14, 2023 Aziyo’s cash balance as of June 30, 2023, was $9.3 million. Conference Call. Aziyo will host a conference call today at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time to …See details»
Aziyo Biologics - Facebook
Aziyo Biologics. 63 likes. Aziyo is the commercial-stage regenerative medicine company focused on creating the next generation oSee details»
Aziyo Biologics Provides Business Update and Preliminary Third …
Oct 25, 2021 Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients …See details»
Aziyo Biologics Announces New Appointments to Board of Directors
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing …See details»
Aziyo Biologics, Inc. (AZYO) Upgraded to Buy: Here's What You …
Jan 26, 2023 Aziyo Biologics, Inc. (AZYO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).See details»
Aziyo Biologics Reports Third Quarter 2021 Financial Results
SILVER SPRING, Md., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next …See details»